Photocure strengthens its management team
Photocure ASA announces the appointment of Ambaw Bellete to its management team, as the Head US Cancer Commercial Operations.
In his new role, Ambaw will provide leadership for the Cysview® commercial operations as Photocure drives forward the new commercial strategy in the US market. Ambaw Bellete has over 20 years experience in the pharmaceutical and medtech industry where he held several executive leadership positions in marketing, sales and commercial operations. He will report directly to the President and CEO, Kjetil Hestdal.
Prior to joining Photocure, Ambaw was President of Medical Compression Systems Inc. in the US, where he spearheaded the launch of a medical device for use in orthopedic surgery. Prior to this, he spent almost ten years at Sanofi Aventis, and was Vice President of the Uro-Injectables franchise in the US. He also held a number of executive positions within several therapeutic business units at Sanofi. Ambaw holds a Bachelor of Science degree in Biology and Chemistry from Murray State University.
In addition the Photocure management team will be expended and further strengthened with the internal appointment of Terry Conrad, Head US Dermatology Commercial Operations and Espen Njåstein, Head Nordic Cancer Commercial Operations. They will join the current management team members Kathleen Deardorff, Inger Ferner Heglund, Grete Hogstad, Gry Stensrud and interim CFO Torbjørn Øye.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
